| Preface | 6 |
---|
| List of Contents | 11 |
---|
| List of Contributors | 13 |
---|
| Learning and Memory | 14 |
---|
| 1 Introduction | 15 |
| 2 Behavioural Paradigms for Studying Aversive Memories | 16 |
| 3 Animal Models | 20 |
| 4 Neurological Substrates of Aversive Memories | 22 |
| 5 Cellular Mechanisms Underlying Aversive Learning and Memory | 26 |
| 6 Clinical Implications | 36 |
| References | 38 |
| Animal Models of Anxiety | 48 |
---|
| 1 Introduction | 49 |
| 2 Tests for Anxiety | 51 |
| 3 Animal Models | 62 |
| 4 General Conclusions | 72 |
| References | 73 |
| Genetic Alterations of the Murine Serotonergic Gene Pathway: The Neurodevelopmental Basis of Anxiety | 83 |
---|
| 1 Introduction | 84 |
| 2 Anxiety-Like Behavior in Knockout Mice | 85 |
| 3 Functional Neuroanatomy of Emotionality: Focus on the Serotonin System | 86 |
| 4 Clinical Implications and Outlook | 113 |
| References | 114 |
| Mutagenesis and Knockout Models: Hypothalamic Pituitary Adrenocortical System | 125 |
---|
| 1 Introduction Understanding Endocrine-Behavior Interactions: Lessons from Mutant Mice | 126 |
| 2 The Stress Hormone (Hypothalamic Pituitary Adrenocortical) System | 127 |
| 3 Gene Targeting: Promises and Caveats | 134 |
| 4 Summary | 144 |
| References | 145 |
| Mutagenesis and Knockout Models: NK1 and Substance P | 154 |
---|
| 1 Introduction | 155 |
| 2 An Overview of the Tachykinin System | 155 |
| 3 Pharmacological Studies | 157 |
| 4 Generation of Knockout Mice | 160 |
| 5 Mechanism of Change in Phenotype in Tac1 and NK1R-Null Mutant Mice | 168 |
| References | 168 |
| Genetic Epidemiology of Anxiety Disorders | 174 |
---|
| 1 Introduction | 175 |
| 2 Assessment and Definitions of Anxiety Disorder | 175 |
| 3 Familial and Genetic Factors | 175 |
| 4 Review of Family and Twin Studies of Anxiety Disorders in Adults | 176 |
| 5 Review of Linkage and Association Studies of Anxiety Disorders | 177 |
| 6 Family Studies and Phenotypic Definitions | 179 |
| 7 High-Risk Studies of Anxiety Disorders | 180 |
| 8 Future Directions for Research on Anxiety | 181 |
| References | 182 |
| Interactions Between Corticotropin-Releasing Hormone and Serotonin: Implications for the Aetiology and Treatment of Anxiety Disorders | 191 |
---|
| 1 Introduction | 192 |
| 2 Neuroanatomical Basis for the Interactions Between CRH and Serotonin | 194 |
| 3 Effects of Central Administration of CRH and Related Peptides on Serotoninergic Neurotransmission | 196 |
| 4 Interactions Between CRH and Serotonin Under Anxiogenic and Psychologically Stressful Conditions: What CanWe Learn from In Vivo Microdialysis Studies? | 199 |
| 5 Consequences of Long-Term Changes in the CRH System for Hippocampal Serotoninergic Neurotransmission | 206 |
| 6 Conclusion | 208 |
| References | 208 |
| Anxiety Disorders: Noradrenergic Neurotransmission | 215 |
---|
| 1 Neural Mechanisms of Anxiety and Fear | 216 |
| 2 Reconsolidation | 219 |
| 3 Extinction | 220 |
| 4 The Neurochemical Basis of Fear and Anxiety | 222 |
| 5 Noradrenergic System | 222 |
| 6 Posttraumatic Stress Disorder | 226 |
| 7 Panic Disorder | 226 |
| 8 Phobic Disorders | 227 |
| 9 Conclusion | 227 |
| References | 228 |
| Pathophysiology and Pharmacology of GABAA Receptors | 234 |
---|
| 1 Inhibitory Interneurons | 235 |
| 2 Diversity of GABAA Receptors | 238 |
| 3 Pathophysiology of the GABA System | 241 |
| 4 Pharmacology of GABAA Receptor Subtypes | 244 |
| 5 Novel Subtype Selective Benzodiazepine Site Ligands | 247 |
| References | 249 |
| Excitatory Amino Acid Neurotransmission | 257 |
---|
| 1 Introduction | 258 |
| 2 Glutamate Receptors | 261 |
| 3 Synaptic Plasticity | 275 |
| 4 Pathophysiology | 277 |
| 5 Summary | 292 |
| References | 293 |
| Neurobiology and Treatment of Anxiety: Signal Transduction and Neural Plasticity | 312 |
---|
| 1 Introduction | 313 |
| 2 Overview of Anxiety-Induced Signal Transduction and Neural Plasticity | 314 |
| 3 Cellular Mechanisms of Stress-Induced Structural Plasticity | 320 |
| 4 Intracellular Signaling Pathways Involved in Fear Memory | 321 |
| 5 Intracellular Signaling Pathways Involved in Anxiety | 327 |
| 6 Intracellular Signal Transduction Pathways in the Treatment of Anxiety | 328 |
| 7 Intracellular Pathways Regulated by Antidepressant Treatment | 329 |
| 8 Intracellular Pathways Regulated by Benzodiazepines | 333 |
| 9 Summary and Conclusions | 334 |
| References | 334 |
| Neuropeptides in Anxiety Modulation | 342 |
---|
| 1 Neuropeptides | 343 |
| 2 Anxiety-Related Behaviour | 345 |